Compare Diageo plc (DEO) vs Danaher Corporation (DHR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diageo plc vs Danaher Corporation — how do they compare? Diageo plc trades at $86.73 (market cap $47.67B), while Danaher Corporation trades at $219.87 (market cap $152.87B). The key difference: Danaher Corporation is far larger — about 3.2× Diageo plc's market cap, and Diageo plc pays the higher dividend (2.3%). Which is the better fit depends on your goals — on Pluang, investors hold Diageo plc for 66 Days and Danaher Corporation for 69 Days on average.
| DEO | DHR | |
|---|---|---|
Market Cap | $47.67B | $152.87B |
Volume | 893,372 | 5,228,698 |
Sector | Consumer Staples | Health |
52-Week High | $102.14 | $242.05 |
52-Week Low | $72.47 | $161.91 |
Typical Hold Time | 66 Days | 69 Days |
Enterprise Value | $68.09B | $175.08B |
Dividend Yield | 2.3% | 0.74% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Diageo (DEO) trades at $86.98, up 2.66% with bullish technical indicators and strong institutional support. The company demonstrates solid fundamentals with consistent earnings beats, a 15.82% ROE, and improving cash flow trends. Recent corporate developments include a new CFO appointment and marketing initiatives across key brands, while analyst consensus remains positive with 49% buy ratings.
The outlook remains favorable with restructuring savings and brand investments driving potential upside, though investors face risks from US market challenges and regulatory pressures. The stock's current valuation at 27.9x P/E appears reasonable given the company's market leadership and turnaround progress under new management.
Danaher (DHR) trades at $217.46, down 0.47% on the day, with a bullish technical signal from moving averages and support at $214. The company shows strong profitability with a 58.51% gross margin and has beaten EPS estimates for three consecutive quarters. Recent news includes a declared $0.40 dividend payable in October 2026 and significant institutional buying, such as Bank of America's new $993.8 million stake in Q2 2026.
The outlook is positive with a consensus price target of $230.31, implying 5.9% upside, supported by 70% analyst buy ratings. Risks include elevated valuation multiples like a P/E of 38.76 and fluctuating cash flows, but earnings growth in biotechnology and steady revenue provide a solid foundation for investor confidence.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diageo plc
Diageo is a global leader in beverage alcohol with an outstanding collection of brands including Johnnie Walker, Smirnoff, and Guinness. It operates a vast portfolio of spirits and beers across more than 180 countries.
Read more on DEO →About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →
